tiprankstipranks
Advertisement
Advertisement
SciSparc discloses patent application for depression yherapy
PremiumThe FlySciSparc discloses patent application for depression yherapy
4M ago
Clearmind Medicine announces Hong Kong patent filing for depression therapy
Premium
The Fly
Clearmind Medicine announces Hong Kong patent filing for depression therapy
4M ago
SciSparc Subsidiary NeuroThera to Take Majority Stake in Quantum Trials Firm CliniQuantum
Premium
Company Announcements
SciSparc Subsidiary NeuroThera to Take Majority Stake in Quantum Trials Firm CliniQuantum
4M ago
SciSparc announces 1-for-9 reverse share split
PremiumThe FlySciSparc announces 1-for-9 reverse share split
4M ago
SciSparc announces 1-for-9 reverse share split
Premium
The Fly
SciSparc announces 1-for-9 reverse share split
4M ago
SciSparc to Enact 1-for-9 Reverse Share Split as Outstanding Shares Shrink
Premium
Company Announcements
SciSparc to Enact 1-for-9 Reverse Share Split as Outstanding Shares Shrink
4M ago
SciSparc Shareholders Approve February Governance Agenda
PremiumCompany AnnouncementsSciSparc Shareholders Approve February Governance Agenda
5M ago
SciSparc files $50M mixed securities shelf
Premium
The Fly
SciSparc files $50M mixed securities shelf
5M ago
SciSparc Subsidiary NeuroThera Wins U.S. Patent for Cannabinoid-Based Antimicrobial Resistance Platform
Premium
Company Announcements
SciSparc Subsidiary NeuroThera Wins U.S. Patent for Cannabinoid-Based Antimicrobial Resistance Platform
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100